The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Proteome profit to be higher than expected thanks to royalties boost

Fri, 26th Mar 2021 13:02

(Alliance News) - Proteome Sciences PLC on Friday said its 2020 profit after tax will be "materially higher" than previously guided because of an increase in royalties.

Shares were up 24% to 4.70 pence in London.

The extra profit is primarily because of higher-than-expected royalty receipts from Thermo Fisher Scientific Inc in the fourth quarter. In January, research services provider Proteome said it expected to report around GBP30,000 profit after tax, down from GBP149,000 in 2019. Revenue was expected to be unchanged at GBP4.6 million.

Proteome recorded a pretax loss in 2019 of GBP36,000 but benefited from a GBP185,000 tax credit that year.

London-based Proteome is due to release its 2020 results on April 1.

By Ivan Edwards; ivanedwards@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrome...

26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's ma...

26 Apr 2024 09:14

LONDON MARKET OPEN: Thoma Bravo snaps up Darktrace for USD5 billion

(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.

10 Apr 2024 11:26

Proteome Sciences shares drop as revenue plunges and swings to loss

(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.